Retinitis: Clinical Trials

11 trials for Retinitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 completed. 11 Phase 3, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 311Completed 11
Phase 22Completed 2

Follow Retinitis: new trials by email Literature Review of Retinitis trials Research Report on Retinitis

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis
Trimethoprim-Sulfamethoxazole - Ocular Toxoplasmosis
Phase 3CompletedUniversity of Campinas, Brazil1412011-10-012016-07-12
Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Ganciclovir implant and oral ganciclovir, Cidofovir intravenous - Cytomegalovirus Retinitis, HIV Infections
Phase 3CompletedJohns Hopkins Bloomberg School of Public Health611997-05-012016-03-14
A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes
Valganciclovir, Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3CompletedHoffmann-La Roche1997-01-012017-05-17
Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT)
MSL-109, Placebo - HIV Infections, Cytomegalovirus Retinitis
Phase 2 / Phase 3CompletedJohns Hopkins Bloomberg School of Public Health2091995-09-012015-11-17
Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT)
Cidofovir - HIV Infections, CMV Cytomegalovirus Retinitis
Phase 2 / Phase 3CompletedJohns Hopkins Bloomberg School of Public Health641994-04-012015-11-17
Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT)
Ganciclovir, Foscarnet - HIV Infections, Acquired Immunodeficiency Syndrome
Phase 3CompletedJohns Hopkins Bloomberg School of Public Health2791992-12-012015-09-14
Ganciclovir Implant Study for Cytomegalovirus Retinitis
Sustained-Release Intraocular Drug Delivery System - HIV Infections, Acquired Immunodeficiency Syndrome
Phase 3CompletedNational Eye Institute (NEI)1992-10-012009-09-17
Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)
Foscarnet, Ganciclovir - HIV Infections, Cytomegalovirus Retinitis
Phase 3CompletedJohns Hopkins Bloomberg School of Public Health2341990-03-012015-10-22
A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis
Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2008-09-30
A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Peripheral Cytomegalovirus Retinitis in Patients With AIDS
Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1802011-03-14
Phase III Ganciclovir +/- rGM-CSF for AIDS-Related CMV Retinitis
Sargramostim, Ganciclovir - Cytomegalovirus Retinitis, HIV Infections
Phase 3CompletedSchering-Plough2005-06-24

Narrower conditions

Cytomegalovirus Retinitis (10)  ·  HIV Infections (10)  ·  Acquired Immunodeficiency Syndrome (5)  ·  Cytomegalovirus Infections (3)  ·  Multiple Acyl Coenzyme A Dehydrogenase Deficiency (3)  ·  AIDS-Related Opportunistic Infections (2)  ·  Chorioretinitis (1)  ·  Neutropenia (1)  ·  Toxoplasmosis, Ocular (1)

Broader conditions

Eye Diseases (11)  ·  Eye Infections (11)  ·  Infections (11)  ·  Retinal Diseases (11)  ·  Blood-Borne Infections (10)  ·  Communicable Diseases (10)  ·  DNA Virus Infections (10)  ·  Eye Infections, Viral (10)  ·  Genital Diseases (10)  ·  Herpesviridae Infections (10)  ·  Immune System Diseases (10)  ·  Immunologic Deficiency Syndromes (10)  ·  Lentivirus Infections (10)  ·  RNA Virus Infections (10)  ·  Retroviridae Infections (10)

Interventions

Ganciclovir (6)  ·  Cidofovir (2)  ·  Foscarnet (2)  ·  Antibodies, Monoclonal (1)  ·  Sulfamethoxazole (1)  ·  Trimethoprim (1)  ·  Trimethoprim, Sulfamethoxazole Drug Combination (1)  ·  Valganciclovir (1)  ·  sargramostim (1)  ·  sevirumab (1)

Sponsors

Johns Hopkins Bloomberg School of Public Health (5)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Hoffmann-La Roche (1)  ·  National Eye Institute (NEI) (1)  ·  Schering-Plough (1)  ·  University of Campinas, Brazil (1)

Countries

United States (5)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Douglas Jabs, MD (2)  ·  Curtis Meinert, PhD (1)  ·  Feinberg J (1)  ·  Jabs D (1)  ·  Rodrigo PC Lira, PhD (1)  ·  Spector SA (1)

Results publications

PMID 31042791, PMID 11919489, PMID 12095806, PMID 12232843, PMID 12559647, PMID 9400786

NIH funding

U10EY008057 (2), U01AI027668 (1)